Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Per the activity note to the FY2024 annual report, the company conducts retail and wholesale trade in medications.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 279 | 160 | 327 | 626 | 573 | 280 | 2,319 | nmf |
| Net Cash used in Investing Activities | 0 | 207 | 152 | 4 | 2 | 158 | 1,242 | +43.1% |
| Free Cash Flow (OCF − Capex proxy) | 279 | 47 | 480 | 622 | 571 | 122 | 1,077 | nmf |
| Net Cash from Financing Activities | 55 | 159 | 389 | 538 | 543 | 19 | 908 | nmf |
| Net Change in Cash (before FX) | 224 | 112 | 90 | 84 | 28 | 103 | 169 | nmf |
| Effect of FX on Cash | 11 | 3 | 5 | 13 | 49 | 14 | 39 | +22.6% |
| Net Change in Cash (incl. FX) | 235 | 115 | 95 | 71 | 21 | 89 | 130 | nmf |
| Cash at Beginning of Year | 263 | 28 | 143 | 47 | 119 | 98 | 187 | -5.6% |
| Cash at End of Year | 28 | 143 | 47 | 119 | 98 | 187 | 317 | +49.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →